Empirical Simulation of Survival and Mixed-Type Data for Clinical Trial Design

📅 2026-08-12
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
Traditional parametric approaches often fail to accurately model complex time-to-event data in clinical trials due to their reliance on prespecified hazard function forms. This work proposes a joint simulation framework based on empirical copulas that integrates nonparametric reconstruction with parametric tail modeling. The method handles right censoring via conditional Kaplan–Meier imputation, models marginal distributions through log-scale location–scale transformations and power distortion of quantile functions, and preserves multivariate rank correlation structures using a Gaussian copula. Remarkably, the approach can reproduce treatment-group survival curves using only a few target quantiles. Applied to a non-small cell lung cancer trial, it successfully replicated both overall survival and progression-free survival curves, yielding a simulated censored Kendall’s tau of 0.522—closely approximating the observed value of 0.549.
📝 Abstract
Simulating realistic time-to-event data is essential for planning and evaluating complex clinical trial designs. Conventional approaches often sample event times from parametric families, such as Weibull or log-normal distributions, which restrict hazard shapes and may poorly represent observed survival data. We propose an empirical copula-based framework for simulating multivariate data containing continuous, binary, count, and right-censored time-to-event variables. The method completes censored historical survival data using a two-zone procedure that combines conditional Kaplan-Meier imputation with a parametric tail. It matches a target survival distribution through a log-scale location-scale transformation and a power distortion of the empirical percentile function, while preserving historical dependence through a Gaussian copula fitted to rank correlations. In an oncology trial of previously treated non-small-cell lung cancer, the method reconstructs overall survival and progression-free survival curves for the experimental arm using control-arm data and a small set of target percentiles. Simulations preserve rank correlations among baseline covariates and the dependence between progression-free and overall survival, with censored Kendall's tau of 0.522 compared with 0.549 in the observed data. The method is implemented in the R package EmpiricalSim.
Problem

Research questions and friction points this paper is trying to address.

survival simulation
mixed-type data
clinical trial design
right-censored data
empirical simulation
Innovation

Methods, ideas, or system contributions that make the work stand out.

empirical copula
survival simulation
censored data imputation
mixed-type data
rank correlation preservation
🔎 Similar Papers
Y
Yao Chen
Indiana University Indianapolis
J
Jiren Sun
Eli Lilly and Company
Y
Yuxin Ding
Eli Lilly and Company
Yushi Liu
Yushi Liu
Shanghai Jiao Tong University
cloud computing
Yongming Qu
Yongming Qu
Eli Lilly and Company
Clinical trial designmissing datageneralized linear modelssurrogate marker